Lisa Mazzullo
Chicago, ILNPI 1952354342
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.8% of the total across 114 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 29.0% of the total.
Across 114 payments — averaging $19.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$651
- Exeltis, USA Inc.$198
- Astellas Pharma US Inc$161
- Bayer$152
- Mayne Pharma Commercial LLC$140
- Merck$119
- plus $823 from 16 others
What the payments were for
- Food & beverage$2,21799%
- Education$261%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 33 | $651 |
| Exeltis, USA Inc. | 9 | $198 |
| Astellas Pharma US Inc | 6 | $161 |
| Bayer | 7 | $152 |
| Mayne Pharma Commercial LLC | 8 | $140 |
| Merck | 8 | $119 |
| Organon | 7 | $116 |
| Biogen | 4 | $85 |
| Hologic Sales And Service, LLC | 4 | $78 |
| Therapeuticsmd, Inc. | 4 | $76 |
| Coopersurgical, Inc. | 4 | $75 |
| Channel Medsystems, Inc. | 2 | $68 |
| Millicent US Inc | 3 | $59 |
| Exact Sciences | 3 | $56 |
| BD | 1 | $35 |
| Lupin Inc. | 2 | $35 |
| Novo Nordisk | 2 | $33 |
| Mission Pharmacal Company | 2 | $28 |
| Vertical Pharmaceuticals, LLC | 2 | $27 |
| AMAG Pharmaceuticals, Inc. | 1 | $19 |
| Pfizer | 1 | $18 |
| Dysis Medical, Inc. | 1 | $17 |
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 72 | $8,668 |
| Estradiol (Twice Weekly)Estradiol | 13 | $1,092 |
| ValacyclovirValacyclovir Hcl | 11 | $760 |
| Clobetasol Propionate | 14 | $719 |
| Fluoxetine Hcl | 12 | $300 |
| Alprazolam | 11 | $11 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.